Cell Science

#Cancer Research Manchester Institute #Cell Science #Lung cancer #Non-animal model (NAM) #Oncology

Cell-based lung cancer model could unlock targeted treatments

Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC) to study the development, activity, and vulnerabilities of the disease.   In the UK, around 80 to 85% of lung cancers are non-small cell lung cancer, of which squamous cell… Read More

#Cancer Research #News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening

Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

Webinar date:
Supported by Ncardia
#Webinars

Heart in a box
#3D cell culture #Advertorial #Biosafety testing #Cell Science #In vitro assays

Ncyte Heart in a Box: Human iPSC-derived 3D cardiac microtissue

This advertorial for Ncardia appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue When hearts are on the line, accuracy is vital.  Ncyte® Heart in a Box™ is a high-purity, high-functional cell product that mirrors the human heart’s complexity in vitro, giving you a physiologically… Read More

#Exclusive Content

Virus and antibodies
#Cell Science #In Focus Report #Market reporting #Organoids

Explore our latest eReport: 3D biology and organoids

Organoids and 3D biology are revolutionising drug discovery, offering more physiologically relevant models to study diseases, screen compounds, and develop personalised treatments. These technologies provide deeper insights into human biology, bridging the gap between in vitro research and clinical success.  In 2024, the field has seen significant… Read More

#News

#Career #Cell Science #ELRIG #Interview #Meet the Researcher #University of Glasgow

Elaine Duncan: A journey in science and outreach

Earlier this year, Elaine Duncan spoke with DDW’s Diana Spencer in a Meet the Researcher interview. At the European Laboratory Research & Innovation Group (ELRIG)'s annual event, Drug Discovery 2024, she again spoke with DDW and told Megan Thomas about her journey to her current multifaceted role both at ELRIG,… Read More

#Exclusive Content

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

New webinar showcases cutting-edge tools for drug discovery

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Webinar: Complex in vitro models and AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Combining complex in vitro models with AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Advancing drug discovery with AI-powered 3D/4D imaging

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids

Advancing drug discovery by combining complex in vitro models with AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA) approaches fall… Read More

Webinar date:
Supported by Zeiss
#Webinars

#3D cell culture #Automation #Automation / robotics #Case study #Cell Science #In vitro

How can automation improve 3D in vitro cell model production?

Download this new Case Study from Hamilton and InSphero, entitled ‘Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation‘. In this Case Study, InSphero, a Swiss-based company specialising in 3D in vitro cell models and cell culture tools for drug discovery, describes: The… Read More

#News

Case Study: Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation
#3D cell culture #Automation #Automation / robotics #Cell Science #In vitro

Enhancing Scalability and Quality of 3D In Vitro Cell Models Production through Automation

In this Case Study, InSphero, a Swiss-based company specialising in 3D in vitro cell models and cell culture tools for drug discovery, describes: The advantages of 3D in vitro cell models for drug discovery The automation of the production of 3D in vitro cell models via InSphero’s Akura™ technology The… Read More

#Resources

#3D cell culture #Assay development optimisation & technology #Biopharmaceuticals #Cell line development #Cell lines #Cell Science #Guide

DDW Cell Line Development Guide 2024

Download the exclusive Guide and read about: What are the benefits cell line development is bringing to biopharmaceutical developers? What technological advances are helping drive efficiencies in cell line development? How is this process underpinning drug development and why is the market growing? In what ways is cell line development… Read More

#DDW eBooks #DDW Guides

#Cell Science #Enhanc3D Genomics #Genetics / genomics #Personalised medicine

How 3D genomics can accelerate personalised medicine

Dr Daniel Turner, Chief Scientific Officer, Enhanc3D Genomics, outlines how 3D genomics offers a radically novel approach to address challenges in drug target discovery and how it can affect change in drug target identification, cell therapy and personalised medicine.  3D genome folding DNA within the cell nucleus is more than… Read More

#Exclusive Content